Probiotic Strains in Fermented Foods

Different fermented foods carry different microbial communities. A serving of yogurt provides perhaps two to four dominant species; a serving of kefir provides 30+; a serving of kimchi cycles through three or four successive populations as it ages. Most of these organisms are Lactobacillus, Bifidobacterium, Streptococcus, Lactococcus, Leuconostoc, Pediococcus, or yeasts, with a handful of Bacillus outliers (the natto bacterium being the most important). Survival through the gastric acid is approximately 10% for most strains — meaning of 10¹⁰ cells consumed, perhaps 10⁹ arrive viable in the small intestine. Most do not permanently colonize the gut and pass through as transient residents within a few days. This page maps which species live in which traditional ferment, the survival-through-gastric-acid data, the transient-vs-colonizing distinction, and the critical commercial-vs-traditional distinction (why most supermarket yogurt provides far less probiotic value than its label suggests).

Table of Contents

1. What Is a Probiotic (and What Is Not)
2. The Lactobacillus Genus — the Workhorses
3. The Bifidobacterium Genus — the Colonic Specialists
4. Streptococcus, Lactococcus, and Pediococcus
5. The Bacillus subtilis var. natto Outlier
6. Yeasts — Saccharomyces, Kluyveromyces, and the Kefir Consortium
7. Species Coverage by Food
8. Survival Through Gastric Acid
9. Transient vs Colonizing Colonization
10. Traditional vs Commercial Yogurt
11. Strain Specificity Matters
12. Cautions
13. Key Research Papers
14. Connections

What Is a Probiotic (and What Is Not)

The formal definition of a probiotic was set by the International Scientific Association for Probiotics and Prebiotics (ISAPP) in their 2014 consensus statement: "live microorganisms that, when administered in adequate amounts, confer a health benefit on the host." Three components matter: live, adequate amount, and demonstrated benefit.

• Live means the organisms must be metabolically viable at the time of consumption. Pasteurization, irradiation, or heat treatment that kills the cells eliminates the "probiotic" designation under the ISAPP definition (though heat-killed preparations may still have postbiotic value — the cells are no longer probiotic but the cell-wall components and produced metabolites can still bind receptors).
• Adequate amount is typically 10⁹–10¹⁰ CFU per dose for most studied strains, though the threshold varies. Sub-threshold doses do not produce measurable effects in randomized trials.
• Demonstrated benefit means a documented health effect in human studies. Many strains carry the "probiotic" name in marketing without any human trial data — this is the area where the term is most often abused.

By contrast, a fermented food need not satisfy these criteria. ISAPP defined fermented foods separately in 2021 (Marco et al.) as "foods made through desired microbial growth and enzymatic conversions of food components." Fermented foods may or may not contain live organisms (sourdough bread is fermented but baked, killing the cells; sauerkraut is fermented and typically eaten raw with live cells). When a fermented food does contain documented strains with documented health effects, it functions as a probiotic delivery vehicle — but the broader category of "fermented" is not synonymous with "probiotic."

This page focuses on the fermented foods that do reliably deliver live probiotic organisms, which is the subset most relevant to the gut-microbiome and immune effects discussed elsewhere in this Benefits hub.

Back to Table of Contents

The Lactobacillus Genus — the Workhorses

The Lactobacillus genus (recently reorganized into multiple genera by Zheng et al. 2020, but most consumers and many practitioners still use the old Lactobacillus umbrella term) is the dominant family of fermentative bacteria in vegetable, dairy, and meat ferments. They are gram-positive, non-spore-forming, rod-shaped bacteria that produce lactic acid from carbohydrate substrates — the lactic-acid production is what drops the pH of a ferment from ~6.5 to ~3.5 and creates the preservative, antimicrobial environment.

Key species and their typical food sources:

• Lactobacillus plantarum — the workhorse of vegetable ferments. Dominant in mid-late phase sauerkraut and kimchi. Highly studied in clinical trials for IBS, antibiotic-associated diarrhea, and immune modulation. One of the most acid-tolerant Lactobacillus species, which improves gastric survival.
• Lactobacillus brevis — vegetable ferments (sauerkraut, kimchi, sourdough). The principal GABA-producing Lactobacillus, with implications for the gut-brain axis. Heterofermentative (produces lactic acid plus CO₂ and ethanol).
• Lactobacillus fermentum — vegetable and dairy ferments, including some kefirs and traditional fermented cereals. Produces folate and B-vitamins.
• Lactobacillus rhamnosus (especially the GG strain) — dairy ferments. Among the most clinically studied probiotic strains, with documented effects in pediatric atopic dermatitis prevention, antibiotic-associated diarrhea, and traveler's diarrhea.
• Lactobacillus acidophilus — traditional yogurt cultures, kefir, supplemented products. Adheres well to intestinal epithelial cells, an unusual property among lactobacilli.
• Lactobacillus casei — aged cheese, traditional dairy ferments, probiotic supplements (the trademarked DN-114 001 strain in Actimel/DanActive).
• Lactobacillus delbrueckii subsp. bulgaricus — the classical yogurt bacterium. Less acid-tolerant than many other lactobacilli; survival rate through the stomach is lower, but the cell-wall fragments and produced metabolites still have immune effects.
• Lactobacillus reuteri — one of the few species that synthesizes vitamin B12 (most lactobacilli are B12-dependent rather than B12-producing). Active research on the DSM 17938 strain for infant colic.
• Lactobacillus kefiri and L. kefiranofaciens — the dominant kefir bacteria, producing the exopolysaccharide kefiran that gives kefir grains their characteristic gelatinous structure.
• Lactobacillus sakei — meat ferments and kimchi. Notable for producing sakacin, a bacteriocin highly active against Listeria monocytogenes.
• Lactobacillus helveticus — cheese ferments, particularly Swiss and Emmental. Produces ACE-inhibitory peptides during milk fermentation, with mild blood-pressure-lowering effects in clinical trials.

Back to Table of Contents

The Bifidobacterium Genus — the Colonic Specialists

Bifidobacterium are gram-positive, anaerobic, Y-shaped (or "bifid", hence the name) bacteria that dominate the infant gut microbiome — particularly in breastfed infants, where they may comprise 90% of the total bacterial community. They decline in relative abundance through childhood and adulthood but remain important members of the healthy adult colonic microbiome. Most species are strict anaerobes, which makes them more difficult to culture and to maintain alive in commercial products.

• Bifidobacterium animalis subsp. lactis — the most commonly added Bifidobacterium in commercial yogurt (the BB-12 strain is a common addition). Relatively oxygen-tolerant for a bifidobacterium, which makes it shelf-stable in dairy products.
• Bifidobacterium bifidum — one of the species typical of breastfed infant guts; supplemented in some probiotic products. Active research on adhesion to intestinal mucus.
• Bifidobacterium longum — broadly distributed in the human gut from infancy through adulthood. Subspecies infantis is specifically adapted to digest human milk oligosaccharides (HMOs) and is the dominant Bifidobacterium in breastfed infants.
• Bifidobacterium breve — another infant-gut species; supplemented in some probiotics and added to some kefirs.
• Bifidobacterium adolescentis — emerges as a dominant Bifidobacterium in the adult gut, displacing some of the infant species.

Note that Bifidobacterium are generally not abundant in traditional vegetable ferments (sauerkraut, kimchi, kombucha) — the species composition in those products is dominated by lactobacilli, leuconostocs, and pediococci. Bifidobacterium are added to many commercial yogurts and probiotic supplements because consumers associate the name with gut health, but for naturally occurring presence in food, kefir and traditional dairy ferments are richer sources than vegetable products.

The role of dietary Bifidobacterium for the adult gut is somewhat debated. The species that are most beneficial in the colon (particularly B. adolescentis) tend to be present already, and their abundance is more reliably increased by feeding them with prebiotic fiber (inulin, FOS, GOS, HMOs) than by attempting to colonize with consumed cells. The exception is the infant gut, where dietary B. longum subsp. infantis supplementation in formula-fed infants has shown durable colonization effects.

Back to Table of Contents

Streptococcus, Lactococcus, and Pediococcus

Beyond the dominant Lactobacillus and Bifidobacterium genera, several other lactic acid bacterial genera contribute to fermented foods:

• Streptococcus thermophilus — the other classical yogurt bacterium, paired with Lactobacillus delbrueckii subsp. bulgaricus. The two have a symbiotic relationship: S. thermophilus grows first and releases amino acids that L. bulgaricus needs, while L. bulgaricus releases formate that S. thermophilus needs. The pairing is what makes yogurt yogurt — without both, the texture and flavor profile are wrong.
• Lactococcus lactis — the foundational cheese-making bacterium and a key kefir component. Produces nisin, an FDA-approved bacteriocin used as a food preservative. L. lactis is one of the better-characterized industrial fermentation organisms.
• Pediococcus pentosaceus and P. acidilactici — meat ferments (salami, summer sausage) and some vegetable ferments. Produce pediocin, another well-studied bacteriocin.
• Leuconostoc mesenteroides — the early-phase colonizer of vegetable ferments. As sauerkraut and kimchi begin fermenting, Leuconostoc is the first to bloom (within 1–3 days), dropping the pH to a level that allows the later lactobacilli to take over. The polysaccharide dextran from Leuconostoc is the active ingredient in some early commercial intravenous plasma volume expanders.
• Leuconostoc kimchii and Weissella koreensis — kimchi-specific species first isolated from traditional Korean kimchi.
• Lactobacillus mesenteroides — the older taxonomy, now reclassified.

These genera are generally underrepresented in commercial probiotic capsules (which focus on lactobacilli and bifidobacteria) but well-represented in traditional fermented foods. This is one of several arguments for variety in fermented food intake — the species you get from a traditional sauerkraut crock are different from those you would get from a refrigerator-section probiotic kombucha, which are different again from those in a Greek yogurt.

Back to Table of Contents

The Bacillus subtilis var. natto Outlier

Bacillus subtilis var. natto deserves its own section because it is biologically very different from the other organisms discussed above. It is a gram-positive, spore-forming, aerobic bacterium — the spore-forming capacity allows it to survive harsh conditions including the gastric acid (estimated survival rate >90%, an order of magnitude higher than typical lactobacilli) and to remain viable through long shelf-stable storage.

B. subtilis var. natto is the bacterium that ferments cooked soybeans into natto, the traditional Japanese breakfast food. The fermentation produces several biologically remarkable compounds:

• Vitamin K2 in the MK-7 form — in much higher concentration than any other dietary source. MK-7 has a half-life of approximately 100 hours in circulation, compared to MK-4 (8 hours) and K1 (~2 hours). The long half-life means a single serving of natto can elevate plasma MK-7 for days. The Rotterdam Study (Geleijnse et al. 2004) found high dietary K2 intake associated with lower arterial calcification and reduced cardiovascular mortality. See our Vitamin K page for details.
• Nattokinase — a 275-amino-acid serine protease with fibrinolytic activity. Several small clinical trials have shown nattokinase reduces blood pressure modestly and improves markers of cardiovascular health. See our Nattokinase page.
• Polyglutamic acid — the slimy "string" of natto, with mild immunomodulatory and prebiotic activity
• Various bioactive peptides — ACE-inhibitory, antimicrobial, antithrombotic

Other Bacillus species are increasingly studied as probiotics in their own right because of their gastric survival advantage. Bacillus coagulans (sometimes marketed as LactoSpore or GanedenBC30) is a spore-former with documented effects in IBS and antibiotic-associated diarrhea. Bacillus clausii is approved as a pharmaceutical probiotic in several European and Latin American countries.

The trade-off with Bacillus probiotics is that they are not native components of the healthy human gut microbiome — they are transient passers-through, like the lactobacilli, but they pass through more reliably because the spores survive the stomach. Whether reliable transit translates to greater clinical effect than the variable transit of Lactobacillus is an open question; both classes have demonstrated benefits in different clinical contexts.

Back to Table of Contents

Yeasts — Saccharomyces, Kluyveromyces, and the Kefir Consortium

Not all fermenters are bacteria. Several traditional ferments rely on yeasts, either as the primary organism or in symbiotic combination with bacteria.

• Saccharomyces cerevisiae — baker's yeast and brewer's yeast. The dominant yeast in sourdough bread, beer, wine, and many kefirs. Generally not considered "probiotic" because it is killed by the baking and boiling that ends most of these fermentations, but in raw forms (some kefirs, some unfiltered beers) it contributes to gut microbiome diversity.
• Saccharomyces boulardii — a probiotic yeast first isolated by Henri Boulard from the skin of lychee and mangosteen fruit in Indochina in the 1920s. It has been extensively studied as a probiotic for antibiotic-associated diarrhea, Clostridioides difficile infection, traveler's diarrhea, and IBD. S. boulardii is not destroyed by antibiotics (since it is a eukaryote, not a bacterium), which makes it uniquely useful as a concurrent probiotic during antibiotic therapy.
• Kluyveromyces marxianus and K. lactis — lactose-fermenting yeasts in kefir grains and some traditional fermented dairy products. They consume the residual lactose in milk, which is one reason kefir is generally better tolerated than fresh milk by lactose-intolerant individuals.
• The kefir grain consortium — kefir grains are not a single organism but a polymicrobial community embedded in a kefiran exopolysaccharide matrix. The community typically includes Lactobacillus kefiranofaciens (which produces the kefiran), 5–15 other Lactobacillus species, Lactococcus lactis, Leuconostoc, plus 5–10 yeast species (Saccharomyces cerevisiae, Kluyveromyces marxianus, Pichia kudriavzevii, and others). The exact species composition varies between kefir grain lineages, which is part of why home-cultured kefirs differ from one batch and household to the next.
• Kombucha SCOBY — another polymicrobial community, this one of acetic acid bacteria (Acetobacter, Gluconobacter, Komagataeibacter) plus yeasts (Brettanomyces, Zygosaccharomyces, Saccharomyces). The yeasts convert sugar to alcohol, the acetic acid bacteria convert the alcohol to acetic acid, and the resulting tea has the characteristic tart, slightly sweet, lightly carbonated profile.

Back to Table of Contents

Species Coverage by Food

The practical table of which species you reliably get from which fermented food:

Back to Table of Contents

Survival Through Gastric Acid

The stomach is hostile to most ingested bacteria. The fasting stomach pH is approximately 1.5–2.0; during a meal it rises to 4–5 as food buffers the acid. Bile in the duodenum is also antimicrobial. Most ingested bacteria are killed by this combination, which is biologically necessary — otherwise every foodborne pathogen would colonize the gut.

The probiotic organisms found in fermented foods have varying degrees of acid and bile tolerance:

• Lactobacillus plantarum — among the most acid-tolerant, with survival rates of 30–50% through simulated gastric transit in laboratory studies
• Lactobacillus rhamnosus GG — well-studied for clinical use; survival rate ~10–30%
• Lactobacillus acidophilus — the name implies acid-loving but survival is moderate, ~10–20%
• Lactobacillus delbrueckii subsp. bulgaricus — one of the more sensitive lactobacilli; survival ~1–5%
• Bifidobacterium species — variable, mostly 5–20%
• Streptococcus thermophilus — relatively sensitive; survival ~5–10%
• Bacillus subtilis var. natto spores — spore form survives essentially intact, >90%
• Saccharomyces boulardii — survival rates ~50–90%, much higher than most bacteria

Survival is dramatically improved by the food matrix. Pure cultures swallowed in water as a slurry are decimated by gastric acid; the same cells embedded in fermented food matrix (the cabbage of sauerkraut, the casein matrix of yogurt) are buffered and protected. This is one of several reasons why fermented foods generally deliver more viable organisms to the small intestine than capsule probiotics of equivalent labeled CFU count.

The fasting-vs-fed timing also matters. Consuming probiotics with a meal, when stomach pH has risen and food matrix is present, improves survival substantially compared to consuming on an empty stomach.

Back to Table of Contents

Transient vs Colonizing Colonization

The single biggest misconception about probiotics in popular health discussion is that ingested bacteria "set up shop" and durably colonize the gut. They generally do not. The vast majority of consumed fermented-food bacteria are transient — they survive the stomach, pass through the small intestine, transit the colon, and are excreted within days of the last consumption. This was demonstrated rigorously by the Zmora et al. 2018 Cell paper from the Weizmann Institute, which used direct endoscopic sampling of probiotic recipients and found that about half showed transient gut colonization while half showed colonization resistance — in both cases, the colonization disappeared within weeks of stopping the probiotic.

This sounds like bad news. If they do not colonize, what is the point? The point is that transient transit still produces meaningful effects:

1. Bacteriocin production — the transient organisms produce antimicrobial peptides during their transit, suppressing pathogen populations
2. Competition for adhesion sites — the transient cells occupy receptor sites on the epithelium that pathogens would otherwise bind
3. Postbiotic delivery — SCFAs, exopolysaccharides, and other metabolites are delivered to the gut during transit
4. Immune signaling — the bacteria engage epithelial pattern-recognition receptors, modulating local and systemic immunity
5. Perturbation of resident community — continuous transit influx may push the resident microbiome toward a more diverse equilibrium

The few exceptions where colonization is more reliable: Bifidobacterium longum subsp. infantis in formula-fed infants (the gut is not yet colonized, so the niche is open); fecal microbiota transplant for recurrent C. difficile (delivering hundreds of species simultaneously, with the resident community already depleted by antibiotics); and certain rare situations of profound dysbiosis. In a healthy adult with established gut flora, expect transient transit and plan accordingly — meaning, consume fermented foods consistently rather than as a "course of treatment."

Back to Table of Contents

Traditional vs Commercial Yogurt

Yogurt is the fermented food the average American consumer is most likely to encounter regularly, but the gap between traditional fermented yogurt and modern commercial yogurt is wide enough to matter clinically. Some commercial yogurt products provide essentially no probiotic value despite the marketing.

What distinguishes a true yogurt from a commercial fake:

• Live and active cultures — the US National Yogurt Association (NYA) "Live and Active Cultures" seal indicates at least 100 million CFU per gram at the time of manufacture. A 6 oz cup with this seal delivers approximately 17 billion CFU at manufacture. Products without this seal are not required to verify culture content.
• Refrigeration — shelf-stable yogurts on unrefrigerated shelves have been heat-treated after fermentation to kill the cultures (this is what "yogurt-style" or "yogurt-flavored" products typically are). Refrigerated yogurts may or may not have live cultures.
• Ingredient list — the simplest yogurts are milk, cream, and live cultures, nothing else. Heavy ingredient lists with starches (modified food starch, pectin, gelatin), sweeteners (sugar, high-fructose corn syrup, sucralose), artificial flavors, and "made with real fruit" fruit syrups indicate a product that has been engineered for shelf life and consumer palatability at the expense of fermentation quality.
• Sugar content — a high-quality plain yogurt has 4–7 grams of sugar per cup, all of it from the lactose. A sweetened "fruit on the bottom" yogurt may have 25+ grams of added sugar, which is a non-trivial nutritional cost for a product that is supposed to be healthy.
• Texture and tartness — properly fermented plain yogurt is tart, somewhat sour, and has a clean texture. Sweetened, starch-thickened products are often texturally smoother and less tart — these features are signs of less complete fermentation, not better fermentation.

The reliable options are: (1) plain whole-milk yogurt with the "Live and Active Cultures" seal, ideally with a short ingredient list and minimal added sugar; (2) Greek-style strained yogurts, which are denser and provide higher protein per serving (and similar cultures); (3) Skyr (Icelandic style), which is even denser; (4) home-cultured yogurt, which is straightforward to make with a packet of starter and a quart of milk. The home-cultured option is the most reliable for live-culture content because the user controls the temperature, time, and post-fermentation handling.

Back to Table of Contents

Strain Specificity Matters

A general principle in probiotic literature: clinical benefits are strain-specific, not species-specific. The fact that Lactobacillus rhamnosus GG (the specific GG strain) prevents antibiotic-associated diarrhea in randomized trials does not mean that other L. rhamnosus strains have the same effect — they may or may not. Each strain has its own genetic background, metabolic profile, and clinical evidence base.

For consumers of fermented foods rather than carefully strain-defined probiotic capsules, this principle has both bad and good implications. The bad: you cannot easily predict which clinical effects a specific food will produce, because the strain composition is variable and largely uncharacterized for traditional ferments. The good: the broad-spectrum exposure to many different strains across many different ferments may be more biologically valuable than dose-matching a single defined strain, because the diversity of inputs maps better to the diversity of the resident gut microbiome.

For specific clinical indications — C. difficile prevention during antibiotics, traveler's diarrhea prevention, atopic dermatitis prevention in high-risk infants, IBS symptom management — the strain-specific probiotic capsule approach has the rigorous trial data and is the appropriate intervention. For general gut and immune health, the broad-spectrum fermented food approach has the Wastyk trial data and is the appropriate intervention. Both have a place; neither makes the other unnecessary.

Back to Table of Contents

Cautions

• Immunocompromised patients. Rare cases of Lactobacillus, Bifidobacterium, and Saccharomyces bloodstream infection have been reported in severely immunocompromised patients given probiotic preparations. The absolute risk is very low, but the patients who are most at risk are precisely the patients most likely to be given probiotics. Discuss with the care team for transplant, chemotherapy, severe neutropenia, or advanced HIV/AIDS patients.
• D-lactate acidosis in short-bowel syndrome. Patients with significant intestinal resection (often for Crohn's disease) can develop D-lactate acidosis from Lactobacillus overgrowth in the residual small intestine. Probiotics may worsen the picture in these patients.
• Histamine production. Some Lactobacillus species (particularly L. brevis and L. buchneri) decarboxylate histidine to histamine. Patients with histamine intolerance or MCAS may experience symptoms from histamine-rich ferments. Lower-histamine options include fresh sauerkraut consumed within days of fermentation, young kombucha, and yogurt with non-histamine-producing strains.
• S. boulardii fungemia in central line patients. Several case reports of S. boulardii bloodstream infection from contamination of central venous catheters in patients given the probiotic. ICU patients with central lines should generally not receive S. boulardii.
• Strain mislabeling in supplements. Multiple analyses have found probiotic supplements containing the wrong species or strain, or far fewer viable cells than the label claims. Quality varies dramatically across brands.

Back to Table of Contents

Key Research Papers

1. Hill C et al. (2014). The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11(8):506-514. — PubMed
2. Marco ML et al. (2021). The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on fermented foods. Nat Rev Gastroenterol Hepatol. — PubMed
3. Zheng J et al. (2020). A taxonomic note on the genus Lactobacillus: Description of 23 novel genera. Int J Syst Evol Microbiol. — PubMed
4. Zmora N et al. (2018). Personalized gut mucosal colonization resistance to empiric probiotics. Cell. — PubMed
5. Wastyk HC et al. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell. — PubMed
6. Suez J et al. (2018). Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. — PubMed
7. Sanders ME et al. (2019). Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. — PubMed
8. Stadlbauer V (2015). Immunosuppression and probiotics: are they effective and safe? Benef Microbes. — PubMed
9. Marco ML et al. (2017). Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol. — PubMed
10. Kim B et al. (2019). Probiotic Bacillus spores tolerate environmental stress conditions including gastric transit. Front Microbiol. — PubMed
11. Cagno R et al. (2013). Exploitation of vegetables and fruits through lactic acid fermentation. Food Microbiol. — PubMed
12. Diosma G et al. (2014). Yeasts from kefir grains: isolation, identification, and probiotic characterization. World J Microbiol Biotechnol. — PubMed

PubMed Topic Searches

• PubMed: L. plantarum probiotic
• PubMed: Bifidobacterium in infants
• PubMed: S. boulardii and AAD
• PubMed: Probiotic gastric survival
• PubMed: Kefir grain microbiology

Back to Table of Contents

Connections

• Fermented Foods Overview
• Fermented Foods Benefits Hub
• Gut Microbiome Diversity
• Immune Function
• History and Cultures
• Probiotics
• Nattokinase
• Vitamin K2 (MK-7 from Natto)
• Vitamin B12
• Kefir
• Kimchi
• Natto
• Yogurt
• Gut Healing
• Gut-Brain Axis
• Gut Microbiome
• Irritable Bowel Syndrome
• All Superfoods

Back to Table of Contents